Mario Gabelli (GRX) discloses large Series E preferred share purchases and put

Rhea-AI Filing Summary

Mario J. Gabelli, a director, 10% owner and control person of the adviser to Gabelli Healthcare & WellnessRx Trust, reported multiple transactions in the trust’s Series E Cumulative Preferred Shares dated 12/26/2025. The filing shows open-market or similar purchases of 1,000,000 Series E shares at $10 per share held directly, plus additional purchases of 500,000 shares through Associated Capital Group, Inc., 200,000 shares through GGCP, Inc., and 100,000 shares through MJG Associates, each at $10 per share.

The report also discloses a disposition of 200,000 Series E shares at $10 per share, described as shares surrendered under a contractual “Right to Put to the Fund” for up to 100% of the outstanding Series E preferred. Gabelli disclaims beneficial ownership of shares held by Associated Capital Group and GGCP beyond his indirect pecuniary interest.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GABELLI MARIO J

(Last) (First) (Middle)

C/O GAMCO INVESTORS, INC.

ONE CORPORATE CENTER

(Street)

RYE NY 10580

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Gabelli Healthcare & WellnessRx Trust [ GRX.E ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)	X	Other (specify below)
			Control Person of Adviser

3. Date of Earliest Transaction (Month/Day/Year)
12/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Series E Cumulative Preferred Shares	12/26/2025		P		500,000	A	$10	700,000	I	Associated Capital Group, Inc.(1)
Series E Cumulative Preferred Shares	12/26/2025		P		200,000	A	$10	200,000	I	GGCP, Inc.(2)
Series E Cumulative Preferred Shares	12/26/2025		J(3)		200,000	D	$10	0	D
Series E Cumulative Preferred Shares	12/26/2025		P		1,000,000	A	$10	1,000,000	D
Series E Cumulative Preferred Shares	12/26/2025		P		100,000	A	$10	100,000	I	MJG Associates(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares reported reflect the total shares owned by Associated Capital Group, Inc. (ACG). Mario J. Gabelli is the Executive Chair and controlling shareholder of ACG. Mr. Gabelli has less than a 100% interest in ACG and disclaims beneficial ownership of the shares held by it which are in excess of his indirect pecuniary interest.

2. The shares reported reflect the total shares owned by GGCP, Inc. (GGCP). Mario J. Gabelli is the Chief Executive Officer, a director, and the controlling shareholder of GGCP. Mr. Gabelli has less than a 100% interest in GGCP and disclaims beneficial ownership of the shares held by it which are in excess of his indirect pecuniary interest.

3. Shares were surrendered in accordance with Right to Put to the Fund up to 100% of Outstanding Series E Cumulative Preferred Shares.

4. Shares are owned by MJG Associates. MJG Associates provides advisory services to private investment partnerships and offshore funds. Mario Gabelli is the sole shareholder, director and employee of MJG Associates.

	Douglas R. Jamieson as Attorney-in-Fact for Mario J. Gabelli	01/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Mario J. Gabelli report for GRX?

Mario J. Gabelli reported several transactions in Series E Cumulative Preferred Shares of Gabelli Healthcare & WellnessRx Trust on 12/26/2025, including large purchases and a surrender of shares under a put right.

How many GRX Series E preferred shares did Mario Gabelli acquire directly?

The report shows a direct acquisition of 1,000,000 Series E Cumulative Preferred Shares of Gabelli Healthcare & WellnessRx Trust at a price of $10 per share.

Which affiliated entities of Mario Gabelli bought GRX Series E preferred shares and in what amounts?

Affiliated entities reported purchases of Series E preferred at $10 per share: Associated Capital Group, Inc. bought 500,000 shares, GGCP, Inc. bought 200,000 shares, and MJG Associates bought 100,000 shares.

What GRX preferred shares were disposed of in this Form 4 filing?

The filing reports a disposition of 200,000 Series E Cumulative Preferred Shares of Gabelli Healthcare & WellnessRx Trust at $10 per share, coded as a transaction where shares were surrendered under a put right.

What is the ‘Right to Put to the Fund’ mentioned in the explanation?

The explanation states that 200,000 Series E preferred shares were surrendered in accordance with a Right to Put to the Fund up to 100% of outstanding Series E Cumulative Preferred Shares, indicating a contractual right to sell shares back to the fund.

How does Mario Gabelli describe his beneficial ownership of shares held by ACG and GGCP?

The filing notes that the reported shares reflect totals owned by Associated Capital Group, Inc. and GGCP, Inc.. Mario Gabelli is the controlling shareholder of both but disclaims beneficial ownership of shares held by these entities in excess of his indirect pecuniary interest.

What is Mario Gabelli’s relationship to Gabelli Healthcare & WellnessRx Trust (GRX)?

Mario J. Gabelli is listed as a Director, a 10% Owner, and an Other – Control Person of Adviser in relation to Gabelli Healthcare & WellnessRx Trust.